Moreover, further studies that focus on optimizing sequences based on the binding sites in NUCKS1 mRNA complementary to tRF-T36 could greatly enhance the efficacy of siRNAs designed to suppress colorectal cancer (CRC). The gene discussed is NUCKS1; the disease is colorectal cancer.